Aprea Therapeutics Inc (APRE) — Financial Flexibility Index
Aprea Therapeutics Inc (APRE) has a Financial Flexibility Index of -0.52x as of March 2026. Free cash flow of $-2.76 Million (operating CF $-2.76 Million minus capex $0.00) represents -1% of total liabilities ($5.30 Million). Check strategic asset allocation of Aprea Therapeutics Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aprea Therapeutics Inc Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Aprea Therapeutics Inc across 10 annual periods. See Aprea Therapeutics Inc (APRE) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Aprea Therapeutics Inc (2007–2025)
Year-by-year free cash flow to debt coverage for Aprea Therapeutics Inc. For the full company profile including market capitalisation, see how much is Aprea Therapeutics Inc worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.69x | $-12.89 Million | $-12.89 Million | $3.49 Million | ▼ -27.4% |
| 2024 | -2.90x | $-13.54 Million | $-13.56 Million | $4.67 Million | ▼ -5.2% |
| 2023 | -2.76x | $-12.08 Million | $-12.18 Million | $4.39 Million | ▲ +50.3% |
| 2022 | -5.54x | $-25.01 Million | $-25.01 Million | $4.51 Million | ▼ -7.6% |
| 2021 | -5.15x | $-37.69 Million | $-37.69 Million | $7.32 Million | ▼ -90.0% |
| 2020 | -2.71x | $-41.78 Million | $-41.80 Million | $15.41 Million | ▲ +4.8% |
| 2019 | -2.85x | $-26.68 Million | $-26.71 Million | $9.36 Million | ▼ -2094.8% |
| 2018 | -0.13x | $-15.25 Million | $-15.25 Million | $117.46 Million | ▲ +43.9% |
| 2017 | -0.23x | $-14.00 Million | $-14.00 Million | $60.53 Million | ▲ +70.4% |
| 2007 | -0.78x | $-1.90 Million | $-1.90 Million | $2.43 Million | — |